Category : Search result: Derivatives Expiry


Generic Semaglutide to Create Rs 50,000 Cr Market

The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.

Tesla Loses Top EV Spot to BYD After 2025 Sales Decline

Tesla's global EV crown slips to China's BYD after a 9% delivery drop in 2025. Intense competition and expiring US tax credits hit sales. Can Musk's robotaxi and robotics pivot revive fortunes? Read the full analysis.

Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Market Cautious on F&O Expiry, Gold & Bitcoin Correct

Indian stock markets consolidate amid F&O expiry and profit booking. Gold prices correct sharply by ₹5,000, Bitcoin slips ₹55,000. Experts share Nifty, Bank Nifty outlook and 8 stock picks for today.

Markets Cautious Ahead of 2025 Year-End Derivatives Expiry

Indian stock markets brace for a cautious final week of 2025 as FPIs and prop traders build significant bearish positions. Nifty expected to trade sideways with a bearish bias amid thin holiday volumes. Key details inside.

Kajol's evolving views on marriage and roles

Kajol's journey from rejecting marital stereotypes to proposing expiry dates reflects a common evolution. A psychologist explains why our ideas of an ideal marriage change over time.

Master the Trader's Trinity for Stock Market Success

Discover the three essential principles—Strategy, Risk Management, and Psychology—that form the foundation for sustainable trading success in India's rapidly evolving stock market. Learn how to navigate volatility and build discipline.

Bitcoin Braces for $23B Options Expiry, High Volatility

Bitcoin's price faces intense pressure as $23 billion in options contracts expire next Friday, threatening to spike volatility. Traders brace for downside risk amid a fragile market. Read the full analysis.

F&O Trading Surges 23% Despite Sebi's Strict Rules

Despite Sebi's intervention to curb risky derivatives trading, retail investors continue to flock to F&O. Average daily premium turnover jumped 23% to ₹75,739 crore in Q3FY26, exceeding pre-curb levels. Explore the data and expert insights.

Sebi Aims to Align Broker & Client F&O Limits

Sebi proposes shifting broker position limits in index derivatives to a delta-adjusted futures-equivalent metric, aligning them with client rules to enhance market stability. Public comments invited until Dec 26, 2025.

Page 1 of 2